Change of Cytokines in Chronic Hepatitis B Patients and HBeAg are Positively Correlated with HBV RNA, Based on Real-world Study
Open Access
- 18 September 2021
- journal article
- research article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 10 (3), 390-397
- https://doi.org/10.14218/jcth.2021.00160
Abstract
The natural course of chronic hepatitis B virus (HBV) infection is widely studied; however, follow-up studies of the same patients are scanty. Here, we studied the dynamic changes of serum HBV RNA and cytokines in hepatitis B virus e antigen (HBeAg)-positive patients treated with entecavir (ETV) to explore the relationship between the HBV serum viral nucleic acids and host immunity.Keywords
This publication has 48 references indexed in Scilit:
- Serum HBV RNA as a possible marker of HBV replication in the liver during nucleot(s)ide analogue therapyThe Esophagus, 2013
- Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patientsThe Esophagus, 2013
- Discriminant value of serum HBV DNA levels as predictors of liver fibrosis in chronic hepatitis BJournal of Viral Hepatitis, 2011
- Involvement of Th17 and Th1 Effector Responses in Patients with Hepatitis BJournal of Clinical Immunology, 2010
- The regulation of IL-10 production by immune cellsNature Reviews Immunology, 2010
- Serum Levels of Interleukin-10 and Interleukin-12 Predict Early, Spontaneous Hepatitis B Virus e Antigen SeroconversionGastroenterology, 2010
- Control of hepatitis B virus replication by innate response of HepaRG cellsJournal of Hepatology, 2009
- The Two Faces of Interleukin 12: A Pro‐inflammatory Cytokine and a Key Immunoregulatory Molecule Produced by Antigen‐Presenting CellsCiba Foundation symposium, 2007
- IFN‐α enhances CD40 ligand‐mediated activation of immature monocyte‐derived dendritic cellsInternational Immunology, 2002
- Predictive indicators for the therapeutic effect of OK-432 in patients with chronic active type B hepatitisBiotherapy, 1992